Login

CEO Spotlight: MeridianLink CEO Nicolaas Vlok shares what excites him most about joining the #NYSECommunity now that his company is public. 00:10:00

Share On Facebook Share On Twitter

Nicolaas Vlok | CEO - MeridianLink, Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Investment Management Operations: Ken Onorio on Leadership and Culture at Eagle Point Credit
00:10:00
Plancorp's 30 Years of Success in Structured Investment Portfolios | Jeff Buckner, Chairman, Plancorp LLC.
00:10:00
Positioning for Market Uncertainty: Strategies and Opportunities for 2023 | Seth Bernstein, CEO , AllianceBernstein AB .
00:10:00
AMC CEO Adam Aron on Reopening New York City Theaters and the Impact of Retail Trading Frenzy | Adam Aron, CEO, AMC Entertainment Holdings Inc.
00:10:00
Award-winning private equity firm that acquires middlemarket consumer and services companies|Scott Johnson,CEO,SJ Partners
00:10:00
The Importance of Inertia and Velocity in Financial Literacy | Joe Pantozzi , President , Alpha Omega Wealth Management LLC.
00:10:00
Introducing From Startup to Centaur a Bessemer Book|David Cowan,Partner,Bessemer Venture Partners
00:10:00
Jonas Wiström Discusses Ratos' Q4 and 2021 Annual Results | Jonas Wiström, CEO, Ratos.
00:00:00
Alligator Bioscience at the ØU Lifescience Investor Conference, November 22, 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
High-Yield Insights: Portfolio Strategy with Tom Johnson and Glenn Stevens - Portfolio Managers at XYZ Capital
00:10:00
Bottle Creek Gold Project Overview
00:10:00
Roxgold Announces New Discoveries and Advancements Across Multiple Projects in Burkina Faso and Cote d'Ivoire

© 2017 - Neuhu+